SignatureFD
BNTX icon

SignatureFD’s BioNTech BNTX Stock Holding History

SignatureFD’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$114K Buy
1,159
+27
+2% +$2.62K ﹤0.01% 1479
2026
Q2 		$105K Sell
1,132
-11
-1% -$1.04K ﹤0.01% 1413
2026
Q1 		$102K Buy
+1,143
New +$117K ﹤0.01% 1341
2025
Q2 		– Sell
-1
Closed -$59 – 3280
2025
Q1 		$59 Buy
+1
New +$112 ﹤0.01% 3284
2024
Q4 		– Sell
-5
Closed -$594 – 3320
2024
Q3 		$594 Buy
+5
New +$460 ﹤0.01% 3072
2024
Q2 		– Sell
-2
Closed -$185 – 3138
2024
Q1 		$185 Hold
2
– – ﹤0.01% 3102
2023
Q4 		$211 Hold
2
– – ﹤0.01% 3055
2023
Q3 		$217 Hold
2
– – ﹤0.01% 3086
2023
Q2 		$216 Sell
2
-375
-99% -$42.2K ﹤0.01% 3131
2023
Q1 		$47K Buy
377
+375
+18,750% +$51.5K ﹤0.01% 1420
2022
Q4 		$300 Hold
2
– – ﹤0.01% 3160
2022
Q3 		$0 Hold
2
– – ﹤0.01% 3119
2022
Q2 		$0 Hold
2
– – ﹤0.01% 3125
2022
Q1 		$0 Buy
+2
New +$336 ﹤0.01% 3150
2021
Q4 		– Sell
-629
Closed -$172K – 3117
2021
Q3 		$172K Buy
+629
New +$200K 0.01% 749

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Davern Capital Partners
Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

SignatureFD's BNTX Position: Q3 2026 in Review

SignatureFD increased its BioNTech (BNTX) stake by 2.4% in Q3 2026, buying an estimated $2.62K and bringing the position to 1,159 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #1479.

SignatureFD first reported a position in BNTX in Q3 2021 and has held it in 15 quarters since. The position peaked at $172K in Q3 2021. 179 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • SignatureFD held 1,159 shares of BioNTech worth $114K as of Q3 2026.
  • SignatureFD bought 27 BioNTech shares in Q3 2026, an estimated $2.62K.
  • BioNTech made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1479 holding.
  • SignatureFD first reported a position in BioNTech in Q3 2021 and has held it in 15 quarters since.
  • SignatureFD's BioNTech position peaked at $172K in Q3 2021.
  • 179 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.